BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24103341)

  • 1. [Retinitis pigmentosa: eye sight restoration by optogenetic therapy].
    Roska B; Busskamp V; Sahel JA; Picaud S
    Biol Aujourdhui; 2013; 207(2):109-21. PubMed ID: 24103341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic therapy for retinitis pigmentosa.
    Busskamp V; Picaud S; Sahel JA; Roska B
    Gene Ther; 2012 Feb; 19(2):169-75. PubMed ID: 21993174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetic approaches to restoring visual function in retinitis pigmentosa.
    Busskamp V; Roska B
    Curr Opin Neurobiol; 2011 Dec; 21(6):942-6. PubMed ID: 21708457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic approaches for retinitis pigmentosa].
    Pach J; Gekeler F
    Klin Monbl Augenheilkd; 2013 May; 230(5):512-8. PubMed ID: 23695848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions.
    Ganjawala TH; Pan ZH
    Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa.
    Busskamp V; Duebel J; Balya D; Fradot M; Viney TJ; Siegert S; Groner AC; Cabuy E; Forster V; Seeliger M; Biel M; Humphries P; Paques M; Mohand-Said S; Trono D; Deisseroth K; Sahel JA; Picaud S; Roska B
    Science; 2010 Jul; 329(5990):413-7. PubMed ID: 20576849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optogenetic approaches to vision restoration.
    Simunovic MP; Shen W; Lin JY; Protti DA; Lisowski L; Gillies MC
    Exp Eye Res; 2019 Jan; 178():15-26. PubMed ID: 30218651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes.
    Phelan JK; Bok D
    Mol Vis; 2000 Jul; 6():116-24. PubMed ID: 10889272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Ophthalmic Optogenetics: Approaches and Applications.
    Prosseda PP; Tran M; Kowal T; Wang B; Sun Y
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategies in RP (retinitis pigmentosa): light at the end of the tunnel?].
    Abegg M; Hafezi F; Wenzel A; Grimm C; Remé CE
    Klin Monbl Augenheilkd; 2000 Feb; 216(2):83-9. PubMed ID: 10730223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring vision using optogenetics without being blind to the risks.
    Harris AR; Gilbert F
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):41-45. PubMed ID: 34724112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated.
    Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-syndromic retinal ciliopathies: translating gene discovery into therapy.
    Estrada-Cuzcano A; Roepman R; Cremers FP; den Hollander AI; Mans DA
    Hum Mol Genet; 2012 Oct; 21(R1):R111-24. PubMed ID: 22843501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the rd1 mouse to understand functional and anatomical retinal remodelling and treatment implications in retinitis pigmentosa: A review.
    Kalloniatis M; Nivison-Smith L; Chua J; Acosta ML; Fletcher EL
    Exp Eye Res; 2016 Sep; 150():106-21. PubMed ID: 26521764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial recovery of visual function in a blind patient after optogenetic therapy.
    Sahel JA; Boulanger-Scemama E; Pagot C; Arleo A; Galluppi F; Martel JN; Esposti SD; Delaux A; de Saint Aubert JB; de Montleau C; Gutman E; Audo I; Duebel J; Picaud S; Dalkara D; Blouin L; Taiel M; Roska B
    Nat Med; 2021 Jul; 27(7):1223-1229. PubMed ID: 34031601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvaging ruins: reverting blind retinas into functional visual sensors.
    Mutter M; Swietek N; Münch TA
    Methods Mol Biol; 2014; 1148():149-60. PubMed ID: 24718800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optogenetic Therapy for Visual Restoration.
    Sakai D; Tomita H; Maeda A
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for retinitis pigmentosa.
    Bennett J
    Curr Opin Mol Ther; 2000 Aug; 2(4):420-5. PubMed ID: 11249772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
    Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.